Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medicenna Therapeutics Corp (MDNAF)

Medicenna Therapeutics Corp (MDNAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Medicenna Therapeutics Corp 200-1920 Yonge Street Toronto A6 M4S 3E2 CAN

www.medicenna.com P: 416-648-5555

Description:

Medicenna Therapeutics Corp is a clinical stage immuno-oncology company. It is engaged in developing engineered versions of IL-2, IL4 and IL13 cytokines called Superkines and Empowered Cytokines ECs for the treatment of cancer. Medicenna Therapeutics Corp is based in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 112,767
Enterprise Value, $K 100,177
Shares Outstanding, K 76,712
Annual Sales, $ 0 K
Annual Net Income, $ -18,880 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,660 K
EBIT, $ -10,530 K
EBITDA, $ -13,840 K
60-Month Beta 1.92
% of Insider Shareholders 33.10%
% of Institutional Shareholders 35.85%
Float, K 51,320
% Float 66.90%
Short Volume Ratio 0.63

Growth:

1-Year Return 422.81%
3-Year Return -42.35%
5-Year Return 28.54%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -35.71%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 07/31/24
Next Earnings Date 08/02/24
Earnings Per Share ttm -0.18
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MDNAF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -79.33%
Return-on-Assets % -65.43%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 7.74
Book Value/Share 0.06
Interest Coverage -2.23
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar